Market Research Logo

Cyprotex Plc (CRX) - Financial and Strategic SWOT Analysis Review

Cyprotex Plc (CRX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cyprotex PLC (Cyprotex) provider of ADME-Tox contract research services. It provides these services to the Biotechnology, pharmaceutical, cosmetics/personal care, and chemical industries. The company’s core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including proprietary CellCiphr toxicity prediction technology, predictive modelling using QSAR and PBPK techniques, including Cloe PK for in vivo PK prediction, and a range of endocrine and skin, ocular disruption services. Cyprotex partners with various organizations within the cosmetics and personal care industry, biotech and pharmaceutical industry, and the chemical industry. The company's operations are primarily carried out in the UK and the US. Cyprotex is headquartered in Cheshire, UK.

Cyprotex Plc Key Recent Developments

Apr 26, 2016: Launch of GLP-Compliant Genotoxicity Services
Nov 17, 2015: Cyprotex Announces Launch of New Solution to Predict Preclinical Toxicity
Oct 15, 2015: Cyprotex Announces Launch of New ADME Guide
Aug 18, 2015: Cyprotex: Interim Results 2015
Jul 16, 2015: Cyprotex launches new Biosciences division

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Cyprotex Plc - Key Facts
Cyprotex Plc - Key Employees
Cyprotex Plc - Key Employee Biographies
Cyprotex Plc - Major Products and Services
Cyprotex Plc - History
Cyprotex Plc - Company Statement
Cyprotex Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Cyprotex Plc - Business Description
Cyprotex Plc - Corporate Strategy
Cyprotex Plc - SWOT Analysis
SWOT Analysis - Overview
Cyprotex Plc - Strengths
Strength - Internal R&D Activities
Strength - Service Portfolio
Strength - Unique Technologies
Cyprotex Plc - Weaknesses
Weakness - Declined Contribution from North America segment
Cyprotex Plc - Opportunities
Opportunity - Acquisition of CeeTox
Opportunity - Expansion Initiatives
Opportunity - New Product Launches
Opportunity - Changing Demographics
Cyprotex Plc - Threats
Threat - Uncertain R&D Outcomes
Threat - Regulations
Threat - Intense Competition
Cyprotex Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cyprotex Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cyprotex Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cyprotex Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 26, 2016: Launch of GLP-Compliant Genotoxicity Services
Nov 17, 2015: Cyprotex Announces Launch of New Solution to Predict Preclinical Toxicity
Oct 15, 2015: Cyprotex Announces Launch of New ADME Guide
Aug 18, 2015: Cyprotex: Interim Results 2015
Jul 16, 2015: Cyprotex launches new Biosciences division
Jul 14, 2015: Cyprotex launches new chemPK workflow solution to predict human pharmacokinetics directly from chemical structure
Apr 14, 2015: Cyprotex launches in vitro service using spontaneously beating cardiac 3D microtissues
Mar 31, 2015: Cyprotex launches new high throughput laboratory in its US facility
Mar 12, 2015: Cyprotex appoints Dr Rob Elsby as Leader of Drug Transporter Team
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Cyprotex Plc, Key Facts
Cyprotex Plc, Key Employees
Cyprotex Plc, Key Employee Biographies
Cyprotex Plc, Major Products and Services
Cyprotex Plc, History
Cyprotex Plc, Subsidiaries
Cyprotex Plc, Key Competitors
Cyprotex Plc, Ratios based on current share price
Cyprotex Plc, Annual Ratios
Cyprotex Plc, Interim Ratios
Cyprotex Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cyprotex Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Cyprotex Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Cyprotex Plc, Performance Chart (2011 - 2015)
Cyprotex Plc, Ratio Charts
Cyprotex Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Cyprotex Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report